73010-36-3 Usage
Uses
Used in Pharmaceutical Industry:
1-(5-METHYLPYRIDIN-2-YL)ACETONE is used as a key building block for the synthesis of pharmaceuticals, contributing to the development of new drugs and therapeutic agents.
Used in Agrochemical Industry:
In the agrochemical sector, 1-(5-METHYLPYRIDIN-2-YL)ACETONE is utilized as a component in the creation of agrochemicals, playing a role in enhancing crop protection and agricultural productivity.
Used in Food and Beverage Industry:
1-(5-METHYLPYRIDIN-2-YL)ACETONE is used as a flavoring agent in the food and beverage industry, adding unique taste profiles to various products.
Used in Fragrance Production:
1-(5-METHYLPYRIDIN-2-YL)ACETONE is also employed in the production of fragrances, where it contributes to the creation of distinct and appealing scents for a wide range of applications.
Used as a Reagent in Organic Chemical Reactions:
1-(5-METHYLPYRIDIN-2-YL)ACETONE serves as a reagent in various organic chemical reactions, facilitating important processes in the synthesis of a broad spectrum of organic compounds.
Check Digit Verification of cas no
The CAS Registry Mumber 73010-36-3 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 7,3,0,1 and 0 respectively; the second part has 2 digits, 3 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 73010-36:
(7*7)+(6*3)+(5*0)+(4*1)+(3*0)+(2*3)+(1*6)=83
83 % 10 = 3
So 73010-36-3 is a valid CAS Registry Number.
InChI:InChI=1/C9H11NO/c1-7-3-4-9(10-6-7)5-8(2)11/h3-4,6H,5H2,1-2H3
73010-36-3Relevant academic research and scientific papers
Pyridine compounds and their pharmaceutical use
-
, (2008/06/13)
A compound of formula (I) wherein each symbol is as defined in the specification, and pharmaceutically acceptable salts thereof. The compound (I) of the present invention and pharmaceutically acceptable salts thereof possess a strong inhibitory activity on the production of nitric oxide (NO), and are useful for prevention and/or treatment of NOS(nitric oxide synthasey)-mediated diseases such as adult respiratory distress syndrome, myocarditis, synovitis, septic shock, insulin-ependent diabetes mellitus, ulcerative colitis, cerebral infarction, rheumatoid arthritis, osteoarthritis, osteoporosis, systemic lupus erythematosus, rejection by organ transplantation, asthma, pain, ulcer, and the like in human being and animals.
